Panel recommends Cymbalta for chronic pain
Friday, August 20, 2010 - 10:35
in Health & Medicine
WASHINGTON, Aug. 20 (UPI) -- The makers of the antidepressant drug Cymbalta have narrowly won approval from a U.S. panel to market it for some chronic pain conditions, officials said. Antidepressant - Chronic pain - Health - Food and Drug Administration - Duloxetine